Other Therapy Areas

Extending our scientific depth across allergy, dermatology, ophthalmology, respiratory, women's health, and more.

Learn More →

    Home > Events > Dct roundtable jan2023

    1 min read

    Executive Roundtable Meeting | Decentralized Trial Solutions for Complex Clinical Trials

    Share your experiences and learn from other

    industry executives

     


    Join Shaheen Limbada, EVP Innovation & Strategy at Veristat, and biotech leader Kathleen Kirby for a thought-provoking roundtable discussion on the latest trends and solutions in decentralized clinical trials.

    As an executive in the biotech industry, you understand the challenges of running complex clinical trials. Patient participation and retention are crucial to the success of any trial, and decentralized solutions are becoming increasingly popular as a way to address these challenges.

     

    At this exclusive event, you'll have the opportunity to:

    • Hear from industry leaders on the latest trends and best practices in decentralized clinical trials
    • Network with peers and gain valuable insights into the challenges and opportunities of decentralized trials
    • Learn about new solutions that can help improve patient participation and retention

     Space is limited, respond no later than February 20th!

     

    DATE: Tuesday, February 28, 2023 
    TIME: 11:30 am – 1:30 pm ET
    LOCATION: Boston College Club, 100 Federal St 36th Floor, Boston, MA 02110
    PARKING: Validated parking at the Post Office Square Garage, 112 Congress St, Boston, MA 02110

     

    Shaheen-Limbada_2019_websiteheadshot_CroppedShaheen Limbada

    Executive Vice President, Innovation and Strategy

    Veristat

     

     


    Learn More

     

    Share This Event:

       

    11 min read

    Monthly FDA Guidance and Regulatory News Review - September 2026

    This September 2026 regulatory update focuses on FDA’s new guidance on neonatal parenteral nutrition compounding and...

    8 min read

    Monthly FDA Guidance and Regulatory News Review - August 2026

    This August 2026 regulatory update focuses on the FDA finalizing three guidances addressing formal sponsor meetings,...